Trends in Drug Discount Management Survey Report

This document is a survey report that examines the current trends and challenges in drug discount management (DDM) faced by leaders in the biopharmaceutical manufacturing industry. It presents findings from a survey of 100 participants, focusing on their concerns regarding pricing pressures, economic uncertainty, and the lack of internal and external collaboration. The report highlights that a significant portion of respondents expressed worries about revenue leakage and the effectiveness of their current technology investments in managing discounts. It also discusses the impact of external factors such as the Inflation Reduction Act and the 340B program on DDM strategies. The insights from Vishali Amin, chief of staff for commercial strategy at Kalderos, provide context on how technology can play a crucial role in addressing these challenges. The report concludes that while many executives recognize the need for improved tech adoption, there remains a gap in fully leveraging available solutions to enhance DDM processes.